PEN-866
- Generic Name
- PEN-866
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C49H49N7O9
- CAS Number
- 1472614-83-7
- Unique Ingredient Identifier
- 56DL1J49LR
- Background
PEN-866 is under investigation in clinical trial NCT03221400 (PEN-866 in Patients With Advanced Solid Malignancies).
- Associated Conditions
- -
- Associated Therapies
- -
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 64
- Registration Number
- NCT04890093
- Locations
- 🇺🇸
Childrens National Medical Center, Washington, District of Columbia, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath